818.93
price down icon1.30%   -10.81
 
loading

Lilly Eli Co Azioni (LLY) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
6.26%
8,768.00
9,353.40 9,498.60 8,312.10 6,960.00
Cost Of Revenue
6.40%
1,673.50
1,788.00 1,860.10 1,807.40 1,626.70
Gross Profit
6.22%
7,094.50
7,565.40 7,638.50 6,504.70 5,333.30
Operating Expenses
9.85%
4,558.40
5,056.60 7,211.30 4,415.80 3,803.60
Interest Income/Expense
29.96%
179.60
138.20 124.60 120.30 102.80
Benefits Costs and Expenses
8.95%
6,231.90
6,844.60 9,071.40 6,223.20 5,430.30
Costs And Expenses
8.95%
6,231.90
6,844.60 9,071.40 6,223.20 5,430.30
Operating Income/Loss
1.09%
2,536.10
2,508.80 427.20 2,088.90 1,529.70
Nonoperating Income/Loss
77.60%
27.10
121.00 -23.20 -36.80 35.70
Income/Loss From Continuing Operations Before Tax
1.09%
2,536.10
2,508.80 427.20 2,088.90 1,529.70
Income Tax Expense/Benefit
8.12%
293.20
319.10 484.60 325.70 184.80
Income/Loss From Continuing Operations After Tax
2.43%
2,242.90
2,189.70 -57.40 1,763.20 1,344.90
Net Income/Loss
2.43%
2,242.90
2,189.70 -57.40 1,763.20 1,344.90
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
4.74M%
900.80
-0.019 899.80 899.70 901.00
Diluted Average Shares
491.10K%
903.80
0.184 899.80 902.70 903.30
Basic Earnings Per Share
2.47%
2.49
2.43 -0.06 1.96 1.49
Diluted Earnings Per Share
2.48%
2.48
2.42 -0.06 1.95 1.49
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
drug_manufacturers_general NVO
$111.94
price down icon 0.01%
$203.55
price down icon 0.16%
drug_manufacturers_general JNJ
$160.13
price up icon 0.17%
drug_manufacturers_general MRK
$101.88
price down icon 0.43%
drug_manufacturers_general NVS
$109.35
price up icon 0.88%
Capitalizzazione:     |  Volume (24 ore):